Stock Analysis
Neogen Corporation (NEOG) Stock Analysis
Neogen Corporation (NEOG) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Neogen Corporation (NEOG) currently has an AIQ Score of 63/100, indicating a neutral setup. Momentum is the strongest factor at 74/100. Value is the weakest current factor at 49/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
NEOG at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $11.08 |
| AIQ Score | 63/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Sell |
| Market Cap | $2.45B |
| P/E Ratio (TTM) | -43.05 |
| Forward P/E | — |
| EPS (Q1 FY2027) | -$0.05 |
| Revenue (Q1 FY2027) | $222.8M |
| Dividend Yield (TTM) | 0.00% |
| Beta | 1.41 |
| Volume | 1.79M |
| 52-week range | $5.37-$14.26 |
| RSI 14 | 40.09 |
| 50-Day SMA | $12.24 |
| 200-Day SMA | $10.51 |
| Analyst Price Target | $14.00 |
| Next Earnings | Jan 14, 2027 |
NEOGNeogen Corporation
Healthcare / Medical - Devices
Low Priority
Above Peers
Latest quote
- Momentum74
- Value49
- Quality63
- Risk resilience57
- Sentiment—
NEOG Stock Analysis Summary
Neogen Corporation (NEOG) currently has an AIQ Score of 63/100, indicating a neutral setup. Momentum is the strongest factor at 74/100. Value is the weakest current factor at 49/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, NEOG has AIQ Score of 63/100 with Momentum base of 74/100 and fading Value at 49/100. Wait for component alignment before adding exposure.
Momentum (74/100) leads while Value (49/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 1.65% stock move · NEOG classified in Medical - Devices.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is NEOG Bullish or Bearish Right Now?
NEOG currently has a neutral overall setup. Momentum is the strongest factor at 74/100, while Value is weakest at 49/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 74/100.
- - Analyst target implies +26.35% upside from the latest quote.
- - Value is the current constraint at 49/100.
- - Technical consensus has more sell votes than buy votes (34 vs 8).
Current Consensus
NEOG's Technical Analysis Consensus is currently Strong Sell, with 8 buy, 4 neutral, and 34 sell votes. NEOG's 14-day RSI is 40.09, which places the stock in a weaker momentum range. NEOG's beta is 1.41, indicating greater market sensitivity than the broad market.
What Changed in NEOG?
The largest recent change in NEOG is Momentum moving down by 4.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the NEOG Outlook?
The current neutral outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
NEOG Decision Framework
Public evidence layers, setup checks, and risk context for Neogen Corporation.
Neogen Corporation (NEOG) Stock Analysis
Neogen Corporation has an AIQ Score of 63/100 in a Neutral regime. Momentum is strongest at 74/100. Beta is 1.41, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | NEOG is in a Neutral AIQ regime with score 63/100. |
| Signal Conflict | The primary conflict is that momentum leads at 74/100 while value lags at 49/100. |
| Factor Evidence | Momentum 74/100 · Value 49/100 · Quality 63/100 · Risk 57/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 74/100.
Momentum is 74/100 and RSI (14) is 40.1.
NEOG is in a Neutral regime at 63/100.
Risk factor is 57/100 with beta 1.41 and annual volatility 57.93%.
Current conflict: momentum leads at 74/100 while value lags at 49/100.
NEOG Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
NEOG Fundamentals
NEOG valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
NEOG Technical Analysis
NEOG technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
NEOG Stock Catalysts
Track NEOG earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
NEOG Dividend Analysis
NEOG dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
NEOG Financial Data
NEOG revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
NEOG Risk Analysis
NEOG volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
NEOG Stock News
NEOG stock news, market tone, recent headlines, and catalyst context.
NEOG vs Medical - Devices Peers
Current peer cohort: NEOG · PACB · PEN · PHG · PRCT. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| NEOG Current stock | 63/100 | 49/100 | 74/100 | 57/100 | 1.19 | 57.93% | Current |
| PACB Pacific Biosciences of California, Inc. | 48/100 | 23/100 | 84/100 | 24/100 | 0.61 | 93.55% | NEOG vs PACB |
| PEN Penumbra, Inc. | 66/100 | 48/100 | 56/100 | 92/100 | 0.62 | 19.46% | NEOG vs PEN |
| PHG Koninklijke Philips N.V. | 72/100 | 80/100 | 72/100 | 73/100 | 0.18 | 29.69% | NEOG vs PHG |
| PRCT PROCEPT BioRobotics Corporation | 49/100 | 38/100 | 60/100 | 45/100 | -0.11 | 65.89% | NEOG vs PRCT |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
Also for NEOG: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Nov 19, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Aug 31, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching NEOG
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for NEOG
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
NEOG Stock FAQ
What is NEOG stock price today?
Neogen Corporation's current stock price is $11.08. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is NEOG bullish or bearish right now?
NEOG's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is NEOG's market cap?
NEOG's market cap is $2.45B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is NEOG's current P/E ratio?
NEOG's current P/E ratio is -43.05 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is NEOG's RSI?
NEOG's 14-day RSI is 40.09 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is NEOG above its 50-day and 200-day moving averages?
NEOG is -8.24% from its 50-day SMA and 6.80% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is NEOG's next earnings date?
NEOG's next earnings date is currently listed as Jan 14, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does NEOG pay a dividend?
NEOG's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.